Monitoring of WT1 Expression in PB and CD34+ Donor Chimerism of BM Predicts Early Relapse in AML and MDS Patients After Hematopoietic Cell Transplantation With Reduced-Intensity Conditioning
Leukemia - United Kingdom
doi 10.1038/leu.2010.283
Full Text
Open PDFAbstract
Available in full text
Date
December 7, 2010
Authors
Publisher
Springer Science and Business Media LLC